Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis

Abstract Despite the associations between diabetic complications and vascular endothelial dysfunction, a direct therapeutic method targeting endothelial dysfunction remains poorly characterized. We have previously shown that chemical inhibition of G-protein-coupled receptor kinase 2 (GRK2) slightly...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kumiko Taguchi, Mari Hida, Mami Hasegawa, Haruka Narimatsu, Takayuki Matsumoto, Tsuneo Kobayashi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6089618781004106a9ed062aad57b2e5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6089618781004106a9ed062aad57b2e5
record_format dspace
spelling oai:doaj.org-article:6089618781004106a9ed062aad57b2e52021-12-02T12:31:50ZSuppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis10.1038/s41598-017-08998-52045-2322https://doaj.org/article/6089618781004106a9ed062aad57b2e52017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08998-5https://doaj.org/toc/2045-2322Abstract Despite the associations between diabetic complications and vascular endothelial dysfunction, a direct therapeutic method targeting endothelial dysfunction remains poorly characterized. We have previously shown that chemical inhibition of G-protein-coupled receptor kinase 2 (GRK2) slightly enhances insulin sensitivity and reduces endothelial dysfunction in type 2 diabetic mice. In this study, we identified GRK2 as a novel therapeutic target of diabetic endothelial dysfunction and investigated the effect on diabetic endothelial dysfunction through the systemic administration of GRK2 siRNA using a hydrodynamic-based procedure, resulting in suppression of increased GRK2 protein levels in the liver. Suppressed GRK2 levels in the liver markedly improved glucose homeostasis, as well as improved the impaired endothelial Akt/eNOS-dependent signal activation (insulin-stimulated phosphorylation of Akt and eNOS) and vascular responses (clonidine-induced and insulin-induced endothelial-dependent relaxation response and phenylephrine-induced contractile response) in type 2 diabetic aortas. Interestingly, insulin-stimulated Akt/eNOS signaling was increased only by normalizing the glucose concentration in human umbilical vein endothelial cells (HUVECs) with GRK2 overexpression, suggesting of an important role of hepatic GRK2. Our results clarified the relationship among hepatic GRK2, glucose homeostasis, and vascular endothelial function. Liver-targeting GRK2 siRNA delivery represents a novel therapeutic tool to restore glucose homeostasis and reduce endothelial dysfunction.Kumiko TaguchiMari HidaMami HasegawaHaruka NarimatsuTakayuki MatsumotoTsuneo KobayashiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kumiko Taguchi
Mari Hida
Mami Hasegawa
Haruka Narimatsu
Takayuki Matsumoto
Tsuneo Kobayashi
Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
description Abstract Despite the associations between diabetic complications and vascular endothelial dysfunction, a direct therapeutic method targeting endothelial dysfunction remains poorly characterized. We have previously shown that chemical inhibition of G-protein-coupled receptor kinase 2 (GRK2) slightly enhances insulin sensitivity and reduces endothelial dysfunction in type 2 diabetic mice. In this study, we identified GRK2 as a novel therapeutic target of diabetic endothelial dysfunction and investigated the effect on diabetic endothelial dysfunction through the systemic administration of GRK2 siRNA using a hydrodynamic-based procedure, resulting in suppression of increased GRK2 protein levels in the liver. Suppressed GRK2 levels in the liver markedly improved glucose homeostasis, as well as improved the impaired endothelial Akt/eNOS-dependent signal activation (insulin-stimulated phosphorylation of Akt and eNOS) and vascular responses (clonidine-induced and insulin-induced endothelial-dependent relaxation response and phenylephrine-induced contractile response) in type 2 diabetic aortas. Interestingly, insulin-stimulated Akt/eNOS signaling was increased only by normalizing the glucose concentration in human umbilical vein endothelial cells (HUVECs) with GRK2 overexpression, suggesting of an important role of hepatic GRK2. Our results clarified the relationship among hepatic GRK2, glucose homeostasis, and vascular endothelial function. Liver-targeting GRK2 siRNA delivery represents a novel therapeutic tool to restore glucose homeostasis and reduce endothelial dysfunction.
format article
author Kumiko Taguchi
Mari Hida
Mami Hasegawa
Haruka Narimatsu
Takayuki Matsumoto
Tsuneo Kobayashi
author_facet Kumiko Taguchi
Mari Hida
Mami Hasegawa
Haruka Narimatsu
Takayuki Matsumoto
Tsuneo Kobayashi
author_sort Kumiko Taguchi
title Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
title_short Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
title_full Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
title_fullStr Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
title_full_unstemmed Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis
title_sort suppression of grk2 expression reduces endothelial dysfunction by restoring glucose homeostasis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/6089618781004106a9ed062aad57b2e5
work_keys_str_mv AT kumikotaguchi suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
AT marihida suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
AT mamihasegawa suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
AT harukanarimatsu suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
AT takayukimatsumoto suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
AT tsuneokobayashi suppressionofgrk2expressionreducesendothelialdysfunctionbyrestoringglucosehomeostasis
_version_ 1718394281046048768